BioSpecifics Technologies Corporation
35 Wilbur Street
Lynbrook
New York
11563-2358
United States
Tel: 516-593-7000
Fax: 516-593-7010
Website: http://www.biospecifics.com/
219 articles about BioSpecifics Technologies Corporation
-
BioSpecifics Technologies Corporation To Host Conference Call To Report Fourth Quarter And Full Year 2013 Financial Results On Thursday, March 6, 2014
2/27/2014
-
BioSpecifics Technologies Corporation Announces Presentations At Upcoming Investor Conferences
2/20/2014
-
BioSpecifics Technologies Corporation Announces Promising Data From CCH Phase 2 In Human Lipoma
1/8/2014
-
BioSpecifics Technologies Corporation Announces Top-Line Data From Phase 2 Trial Of CCH For Canine Lipoma
12/23/2013
-
FDA Approves BioSpecifics Technologies Corporation's First Drug Treatment For Peyronie's Disease
12/6/2013
-
BioSpecifics Technologies Corporation Announces Positive Top-Line Data From XIAFLEX® MULTICORD Phase 3b Study
11/18/2013
-
BioSpecifics Technologies Corporation Reports Third Quarter 2013 Financial Results
11/12/2013
-
BioSpecifics Technologies Corporation to Host Conference Call to Report Third Quarter 2013 Financial Results on Tuesday, November 12, 2013
11/5/2013
-
BioSpecifics Technologies Corporation Announces Initiation of Phase 2a Study of XIAFLEX for Treatment of Cellulite
10/23/2013
-
BioSpecifics Technologies Corporation Announces Data from Multiple Studies of XIAFLEX for Treatment of Dupuytren's Contracture Presented at American Society for Surgery of the Hand 2013
10/8/2013
-
BioSpecifics Technologies Corporation to Present at the Aegis Capital 2013 Healthcare Conference
9/20/2013
-
BioSpecifics Technologies Corporation to Present at the Stifel Nicolaus 2013 Healthcare Conference
9/4/2013
-
BioSpecifics Technologies Corporation Reports Second Quarter 2013 Financial Results
8/8/2013
-
BioSpecifics Technologies Corporation to Host Conference Call to Report Second Quarter 2013 Financial Results on Thursday, August 8, 2013
8/1/2013
-
BioSpecifics Technologies Corporation Announces Data from Collaborative Uterine Fibroid Study Presented at 2013 Society for the Study of Reproduction Annual Meeting
7/23/2013
-
BioSpecifics Technologies Corporation Announces Partnership Between Auxilium Pharmaceuticals and Swedish Orphan Biovitrum for XIAPEX in Eurasia and Africa
7/17/2013
-
BioSpecifics Technologies Corporation to Present at the 8th Annual JMP Securities Healthcare Conference
7/2/2013
-
BioSpecifics Technologies Corporation to Present at Jefferies and Co. 2013 Global Healthcare Conference
5/28/2013
-
BioSpecifics Technologies Corporation Reports First Quarter 2013 Financial Results
5/10/2013
-
BioSpecifics Technologies Corporation to Host Conference Call to Report First Quarter 2013 Financial Results on Friday, May 10, 2013
5/3/2013